Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ruizhi Health (Ruizhi Yueran Health Technology) is a Shanghai-based biotechnology company specializing in advanced diagnostic and health management solutions. The company focuses on early cancer screening and precision health monitoring using proprietary exosome and DNA methylation technologies. Its flagship products include non-invasive exosome-based early screening for ovarian cancer, methylation-based multi-cancer screening, and telomere length testing for biological age assessment. Ruizhi Health integrates R&D, laboratory testing, and health consulting to provide comprehensive wellness and diagnostic services to urban populations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shanghai Ruizhi Health Technology.